News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Aging | Aging the brain: multi-region methylation principal component based clock in the context of Alzheimer’s disease

Aging

August 1, 2022
PRESS RELEASE: A new research paper was published in Aging on the cover of Volume 14, Issue 14, entitled, “Aging the brain: multi-region methylation principal component based clock in the context of Alzheimer’s disease.” continue reading »

Aging | Age-related neuroendocrine, cognitive, and behavioral co-morbidities are promoted by HIV-1 Tat expression in male mice

Aging

July 28, 2022
PRESS RELEASE: A new research paper was published in Aging's Volume 14, Issue 13, entitled, “Age-related neuroendocrine, cognitive, and behavioral co-morbidities are promoted by HIV-1 Tat expression in male mice.” continue reading »

Oncotarget | CUDC907 promotes apoptosis of NF2 Schwannoma cells

Oncotarget

July 26, 2022
PRESS RELEASE: A new research paper was published in Oncotarget on July 19, 2022, entitled, “CUDC907, a dual phosphoinositide-3 kinase/histone deacetylase inhibitor, promotes apoptosis of NF2 Schwannoma cells.” continue reading »

Oncotarget | Predicting cancer immunotherapy response from gut microbiomes using machine learning models

News

July 19, 2022
PRESS RELEASE: A new research paper was published in Oncotarget on July 19, 2022, entitled, “Predicting cancer immunotherapy response from gut microbiomes using machine learning models.” continue reading »

Aging | Epigenetic clocks and their association with perceived discrimination and depressive symptoms

Aging

July 18, 2022
PRESS RELEASE: A new research paper was published on the cover of Aging's Volume 14, Issue 13, entitled, “Epigenetic clocks and their association with trajectories in perceived discrimination and depressive symptoms among US middle-aged and older adults.” continue reading »